The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1470
Drugs for Psoriasis
The full article is available to subscribers Subscriber Login   

Mild to moderate psoriasis is generally treated with topical corticosteroids. Vitamin D analogs and tazarotene are topical alternatives that can be used in combination with topical corticosteroids. Phototherapy and systemic therapy, including biologic agents, are recommended for patients with moderate to severe disease.

Drugs for psoriatic arthritis are reviewed in a separate article available at http://medicalletter.org/TML-article-1470d.

TOPICAL THERAPY — Corticosteroids – Topical corticosteroids are widely used for treatment of psoriasis both alone and in combination with phototherapy and systemic therapy. Ointments are generally the most effective. Foams and sprays can be applied to large areas, but the alcohol base used in many of them may cause burning in patients with sensitive skin.

Adverse Effects – Superpotent topical corticosteroids, such ... more       Show References Hide References

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Drugs for Psoriasis
Article code: 1470a
 Electronic, downloadable article - $25